-
373Wire StoriesCoeur Provides Palmarejo Exploration Update
CHICAGO–(BUSINESS WIRE)–Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today provided an update on the exploration programs at its Palmarejo gold-silver...
-
397Wire StoriesGlobal Economic Boom Boosts Commercial Banks Revenue, Set to Reach $2.8 Trillion in 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Commercial Banks – Industry Market Research Report” has been added to ResearchAndMarkets.com’s offering. The industry closely follows global economic...
-
498Wire StoriesAnteris Technologies Commences American Depository Receipt Program
BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)–Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that it has established a...
-
422Wire StoriesOptions Chosen as Primary Market Data Provider for GO Markets’ Expansion into Asian Markets
LONDON & NEW YORK & HONG KONG–(BUSINESS WIRE)–Options Technology, the leading provider of financial technology and global market data solutions, today announced...
-
426Wire StoriesAnteris Technologies Commences US Early Feasibility Study
BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)–Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ Transcatheter Heart...
-
439Wire StoriesCoca-Cola Bottlers Japan and Accenture to Establish Joint Venture
The new entity will promote data-driven management by streamlining administrative and back-office operations of Coca-Cola Bottlers Japan Group TOKYO–(BUSINESS WIRE)–Coca-Cola Bottlers Japan...
-
396Wire Stories
Parade Technologies Reports Second Quarter 2023 Financial Results
Financial Highlights: Q223 consolidated revenue US$104.18 million, compared with US$216.70 million in the year-ago quarter Q223 consolidated net income US$13.98 million; Basic...
-
516Wire StoriesMeiji Seika Pharma Announces Positive Results in Phase II Study of ME3183, a Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Moderate-to-Severe Plaque Psoriasis in the United States and Canada
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi) today announced that ME3183, a novel highly-potent selective...
-
417NewsSyfe Hong Kong launches Income+ with target monthly payouts of up to 8.6% p.a.
New offering enables investors to seize market opportunities and grow passive income HONG KONG SAR – Media OutReach – 9 August 2023...
-
369News
“JD-Just Dating” App’s Online Dating Survey in Hong Kong Reveals: 70% Have Met Online
Women More Proactive Than Men in Seeking Romance, Preferring “Mature Men” HONG KONG SAR – Media OutReach – 9 August 2023 –...
